Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2298 (LINC02298) is an annotated long non-coding RNA gene that does not overlap with protein-coding genes and appears to be transcribed autonomously. As a member of the lincRNA family, it is presumed to participate in gene expression regulation, possibly by modifying chromatin states, scaffolding regulatory proteins, influencing transcription or stabilizing RNAs, although no specific biological, disease, or therapeutic roles have been documented for LINC02298 itself. No evidence currently supports LINC02298 as a therapeutic target, clinical biomarker, or cause of disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2298 (LINC02298).